Ayuda
Ir al contenido

Dialnet


Olanzapine Linked With Potentially Fatal Skin Reaction

  • Autores: Rebecca Voelker
  • Localización: JAMA: the journal of the American Medical Association, ISSN 0098-7484, Vol. 315, Nº. 23, 2016, pág. 2514
  • Idioma: inglés
  • Texto completo no disponible (Saber más ...)
  • Resumen
    • Nearly 2 dozen cases of a rare but serious skin reaction linked over the past 20 years with the antipsychotic medication olanzapine have prompted a warning from the FDA.

      The agency will add information to drug labels for all olanzapine-containing products warning that they may cause drug reaction with eosinophilia and systemic symptoms (DRESS), which can start as a rash that sometimes spreads across the entire body. Fever, swollen lymph nodes, and a swollen face may accompany the rash. The condition results in a higher-than-normal number of eosinophils that can cause inflammation or swelling. In severe cases, damage to organs including the liver, kidneys, lungs, heart, or pancreas may occur.


Fundación Dialnet

Dialnet Plus

  • Más información sobre Dialnet Plus

Opciones de compartir

Opciones de entorno